Jeil Pharmaceutical Co.,Ltd (KRX: 271980)

Jeil Pharmaceutical Co.,Ltd Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 15, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	187,973	249,173	306,279	494,529	-	-
Market Cap Growth	-19.25%	-18.65%	-38.07%	-	-	-
Enterprise Value	243,573	307,855	346,439	503,520	-	-
Last Close Price	12900.00	17100.00	20937.87	33666.52	62145.88	35895.53
PE Ratio	-	49.85	-	-	131.32	-
PS Ratio	0.27	0.34	0.42	0.71	-	-
PB Ratio	1.09	1.46	1.87	2.96	-	-
P/TBV Ratio	1.32	1.62	1.99	3.01	-	-
P/FCF Ratio	-	-	-	35.95	-	-
P/OCF Ratio	-	-	-	25.89	-	-
EV/Sales Ratio	0.35	0.42	0.48	0.72	-	-
EV/EBITDA Ratio	-	16.50	-	-	-	-
EV/EBIT Ratio	-	34.64	-	-	-	-
EV/FCF Ratio	-32.87	-	-	36.60	-	-
Debt / Equity Ratio	0.39	0.42	0.33	0.29	0.29	0.19
Debt / EBITDA Ratio	-	3.82	-	-	2.30	4.50
Debt / FCF Ratio	-	-	-	3.47	-	1.16
Asset Turnover	1.43	1.54	1.64	1.68	1.71	-
Inventory Turnover	4.50	5.19	5.61	5.15	5.53	-
Quick Ratio	0.69	0.66	0.71	0.78	0.75	0.84
Current Ratio	1.11	1.04	1.12	1.28	1.27	1.27
Return on Equity (ROE)	-20.79%	3.11%	-9.06%	-8.82%	4.08%	-
Return on Assets (ROA)	-2.70%	1.18%	-1.89%	-1.55%	1.92%	-
Return on Capital (ROIC)	-5.13%	2.41%	-3.85%	-2.97%	3.67%	-
Earnings Yield	-19.02%	2.01%	-4.27%	-2.52%	-	-
FCF Yield	-3.94%	-4.45%	-8.56%	2.78%	-	-
Dividend Yield	0.40%	0.29%	0.24%	-	-	-
Payout Ratio	0.00%	14.55%	-	-	14.79%	-
Buyback Yield / Dilution	0.01%	0.02%	0.23%	0.04%	0.41%	-
Total Shareholder Return	0.41%	0.31%	0.47%	0.04%	0.41%	-

Source: S&P Capital IQ. Standard template. Financial Sources.